ReviewPharmaceutics2022

Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen.

André Farkouh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.